Overall Score

Bargaining Power Of Suppliers

Moderate supplier power due to AZTA’s specialized manufacturing and consumables inputs, but no evidence of acute supply disruption.

Healthy liquidity and low leverage reduce near-term vulnerability to supplier pricing pressure.

Bargaining Power Of Buyers

Buyer power remains meaningful because AZTA operates in a competitive life-sciences tools market with price sensitivity.

Weak profitability and negative margins limit pricing leverage, though a current ratio of 2.50 and cash per share of 7.19 support continuity.

Threat Of New Entrants

Barriers to entry remain moderate from technical know-how, installed base relationships, and product validation requirements.

However, the company’s modest scale and price-to-sales of 2.52 suggest the market is not protected by exceptionally high structural barriers.

Threat Of Substitutes

Substitution risk is moderate because customers can shift among alternative lab automation and sample prep workflows.

AZTA’s gross margin of 44.0% indicates some differentiation, but not enough to eliminate substitute pressure.

Rivalry Among Existing Competitors

Competitive rivalry is elevated given negative EBIT margin of -24.8% and net margin of -20.0%, which point to intense industry competition and pricing pressure.

The company’s low debt burden and current ratio of 2.50 provide resilience, but do not materially reduce rivalry intensity.